Keyphrases
Tolerability
100%
Prednisone
100%
Limb-girdle muscular Dystrophy
100%
Once-weekly
100%
Exploratory Clinical Trial
100%
Duchenne muscular Dystrophy
33%
Muscle Performance
33%
Disease Course
16%
Large Cohort
16%
Mouse Model
16%
Blood Pressure
16%
Adiposity
16%
Standard of Care
16%
Lean Mass
16%
Blood Biomarkers
16%
Muscular Dystrophy
16%
Body Composition
16%
Vital Signs
16%
Whole-body
16%
Functional Measures
16%
Muscle Atrophy
16%
Lipid Profile
16%
Single Center
16%
Single-center Study
16%
HgbA1c
16%
Muscle Measurement
16%
Serum Creatine Kinase
16%
Non-ambulatory
16%
Limb-girdle
16%
Pharmacology, Toxicology and Pharmaceutical Science
Tolerability
100%
Clinical Trial
100%
Limb Girdle Muscular Dystrophy
100%
Prednisone
100%
Glucocorticoid
33%
Duchenne Muscular Dystrophy
33%
Mouse Model
16%
Preclinical Study
16%
Biological Marker
16%
Obesity
16%
Side Effect
16%
Muscular Dystrophy
16%
Disease Course
16%
Muscle Atrophy
16%
Creatine Kinase
16%
Nursing and Health Professions
Prednisone
100%
Limb Girdle Muscular Dystrophy
100%
Glucocorticoid
33%
Duchenne Muscular Dystrophy
33%
Health Care Quality
16%
Pilot Study
16%
Dual Energy X Ray Absorptiometry
16%
Body Composition
16%
Preclinical Study
16%
Creatine Kinase Blood Level
16%
Blood Pressure
16%
Disease Course
16%
Biological Marker
16%
Obesity
16%
Vital Sign
16%
Side Effect
16%
Muscle Atrophy
16%
Muscular Dystrophy
16%